This models has, accordingly, been used in studies on pathophysiology of impaired glucose tolerance and T2D: it is characterized by fasting hyperglycemia, which contributes in reducing glucose-mediated insulin secretion and in the efficiency of glucose uptake by the insulin sensitive tissues [37, 36]. The gene discussed is INS; the disease is Impaired glucose tolerance.